期刊
BIOMOLECULES
卷 11, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/biom11111692
关键词
diabetes mellitus; natural compounds; QSAR; molecular docking; molecular dynamics; blood-brain barrier; in silico
资金
- Romanian National Authority for Scientific Research and Innovation, CNCS/CCCDI-UEFISCDI [PN-III-P2-2.1-PED-2019-4771, PN-III-P2-2.1-PED-2019-1264, PN-III-P2-2.1-PED-2019-5283, PN-III-P2-2.1-PED-2019-1471, PN-III-P4-ID-PCE-2020-0620]
- Nucleu Programme [16N/08.02.2019]
Diabetes is a serious health issue with unclear molecular mechanisms and severe side effects associated with current synthetic drug treatments. Natural compounds from plants have shown promising anti-diabetic activity, as well as benefits for lipid-lowering and anti-obesity. Bioinformatics tools are used to study the mechanisms of action of these compounds, particularly focusing on blood-brain barrier permeability in relation to diabetes.
Diabetes represents a major health problem, involving a severe imbalance of blood sugar levels, which can disturb the nerves, eyes, kidneys, and other organs. Diabes management involves several synthetic drugs focused on improving insulin sensitivity, increasing insulin production, and decreasing blood glucose levels, but with unclear molecular mechanisms and severe side effects. Natural chemicals extracted from several plants such as Gymnema sylvestre, Momordica charantia or Ophiopogon planiscapus Niger have aroused great interest for their anti-diabetes activity, but also their hypolipidemic and anti-obesity activity. Here, we focused on the anti-diabetic activity of a few natural and synthetic compounds, in correlation with their pharmacokinetic/pharmacodynamic profiles, especially with their blood-brain barrier (BBB) permeability. We reviewed studies that used bioinformatics methods such as predicted BBB, molecular docking, molecular dynamics and quantitative structure-activity relationship (QSAR) to elucidate the proper action mechanisms of antidiabetic compounds. Currently, it is evident that BBB damage plays a significant role in diabetes disorders, but the molecular mechanisms are not clear. Here, we presented the efficacy of natural (gymnemic acids, quercetin, resveratrol) and synthetic (TAK-242, propofol, or APX3330) compounds in reducing diabetes symptoms and improving BBB dysfunctions. Bioinformatics tools can be helpful in the quest for chemical compounds with effective anti-diabetic activity that can enhance the druggability of molecular targets and provide a deeper understanding of diabetes mechanisms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据